BPI
WST icon

BFC Planning, Inc.’s West Pharmaceutical WST Stock Holding History

BFC Planning, Inc.’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
775
+50
+7% +$15.3K 0.01% 822
2026
Q1 		$182K Sell
725
-151
-17% -$37.6K 0.01% 908
2025
Q4 		$241K Buy
876
+76
+10% +$20.8K 0.01% 807
2025
Q3 		$210K Sell
800
-94
-11% -$22.8K 0.02% 652
2025
Q2 		$196K Buy
894
+15
+2% +$3.21K 0.02% 646
2025
Q1 		$197K Buy
879
+282
+47% +$77.7K 0.02% 619
2024
Q4 		$196K Buy
+597
New +$188K 0.02% 623

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BFC Planning, Inc.'s WST Position: Q2 2026 in Review

BFC Planning, Inc. increased its West Pharmaceutical (WST) stake by 6.9% in Q2 2026, buying an estimated $15.3K and bringing the position to 775 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #822.

BFC Planning, Inc. first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 839 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • BFC Planning, Inc. held 775 shares of West Pharmaceutical worth $278K as of Q2 2026.
  • BFC Planning, Inc. bought 50 West Pharmaceutical shares in Q2 2026, an estimated $15.3K.
  • West Pharmaceutical made up 0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #822 holding.
  • BFC Planning, Inc. first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 839 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.